StockVS

NYSE · Medical Care Facilities · USD

PACS Group, Inc. (PACS) Stock Analysis

PACS Group, Inc. (PACS) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.

PACS

$42.50

−$0.57 (−1.32%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PACS with… →

PACS Key Statistics

As of Sep 4, 2026
Trading
Open
$42.61
Previous Close
$43.07
Day's Range
42.11–43.19
52-Week Range
7.50–49.49
Volume
649.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.13
Valuation
Market Cap
$6.73B
P/E Ratio
24.85
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
15.66
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.09
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.21
EPS (ttm)Profit attributable to each share over the last twelve months.
1.71
Financials (FY)
Revenue (FY)
$5.29B+29.32%
Net Income (FY)
$191.54M+243.51%
Profit marginThe share of revenue left as profit after all costs and taxes.
4.85%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
158.34M
1-Year Return
+278.45%
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
874.56K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PACS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+10.71%
2025+192.83%
2024 (partial year)−43.00%

As of September 4, 2026.

PACS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$5.29B$191.54M3.6%
2024$4.09B$55.76M1.4%
2023$3.11B$112.87M3.6%
2022$2.42B$150.50M6.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$5.29B$780.33M$309.60M$191.54M3.6%
2024$4.09B$507.69M$123.07M$55.76M1.4%
2023$3.11B$447.07M$207.77M$112.87M3.6%
2022$2.42B$400.68M$229.36M$150.50M6.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PACS Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricPACSMedical Care Facilities medianvs median
P/E24.8519.8425% above
P/S ratio1.210.9528% above
Profit margin4.85%3.06%1.8 pts above

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

PACS Group, Inc. (PACS) is capitalised at $6.73B on the latest close. It is classified in the Medical Care Facilities industry, within the Healthcare sector. Headcount on file is 47,455.

Over the past 52 weeks the price has ranged from $7.50 to $49.49. The most recent close on file for PACS is $42.50, dated September 4, 2026. That is −$0.57 (−1.32%) against the previous close. The latest close sits 466.67% above that 52-week low.

Financial Health

In fiscal 2025, PACS Group, Inc. reported revenue of $5.29B. Against the prior fiscal year total of $4.09B, that is a change of +29.32%. Net income for the same year was $191.54M. That is +243.51% against the prior fiscal year. The reported profit margin is 4.85%. That is 1.8 percentage points above the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to 1.71.

Across the 4 fiscal years on file, revenue moves from $2.42B in 2022 to $5.29B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

PACS trades at a trailing price-to-earnings ratio of 24.85. That is 25.25% above the Medical Care Facilities median of 19.84. On forward earnings the ratio is 15.66. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.09. The price-to-sales ratio is 1.21. On price-to-sales that is 27.54% above the Medical Care Facilities median of 0.95. The medians here are taken across 57 Medical Care Facilities companies that report the metric.

The reported beta is −0.13. Daily returns over the trailing 2 years annualize to a volatility of 87.07%. The trailing one-year price return is +278.45%. The stored price history starts on April 11, 2024, and the total return since then is +84.78%.

Growth & Income

The record shows no dividend for PACS.

2026 is still running; the price is +10.71% year to date. The record holds one complete calendar year, 2025, which returned +192.83%.

Peer Comparison

PACS Group, Inc. (PACS) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
PACS Group, Inc. PACS $6.73B 24.9
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. PACS Group, Inc. trades at a P/E of 24.9.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

View all Medical Care Facilities stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About PACS Group, Inc.

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

Visit website →